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Inhalation of environmental antigens such as aller-
gens does not always induce inflammation in the res-
piratory tract. While antigen-presenting cells (APCs),
including dendritic cells and macrophages, take up
inhaled antigens, the cell-intrinsic molecular mecha-
nisms that prevent an inflammatory response during
this process, such as activation of the transcription
factor NF-kB, are not well understood. Here, we
show that the nuclear receptor PPARg plays a critical
role in blocking NF-kB activation in response to
inhaled antigens to preserve immune tolerance.
Tolerance induction promoted mitochondrial respi-
ration, generation of H2O2, and suppression of NF-
kB activation in WT, but not PPARg-deficient,
APCs. Forced restoration of H2O2 in PPARg-deficient
cells suppressed IkBa degradation and NF-kB acti-
vation. Conversely, scavenging reactive oxygen spe-
cies from mitochondria promoted IkBa degradation
with loss of regulatory and promotion of inflamma-
tory T cell responses in vivo. Thus, communication
between PPARg and the mitochondria maintains im-
mune quiescence in the airways.
INTRODUCTION
Inhalation of antigen/allergen is a natural and spontaneous pro-
cess, which normally maintains immune tolerance in the airways
(Curotto de Lafaille et al., 2008; Khare et al., 2013, 2015;
McMenamin et al., 1994; Ostroukhova et al., 2004). This process
of tolerance prevents inflammatory immune responses to1700 Cell Reports 15, 1700–1714, May 24, 2016 ª 2016 The Author(s
This is an open access article under the CC BY-NC-ND license (http://inhaled antigens that, in susceptible individuals, can lead to
allergic diseases such as asthma (Lambrecht and Hammad,
2012). Immune tolerance also prevents autoimmune diseases
and transplant rejections. Antigen-presenting cells (APCs) such
as dendritic cells (DCs) play a central role in the decision-making
process between immune activation and tolerance (Steinman,
2012). It is, therefore, important to understand the molecular
mechanisms by which APCs mediate immune tolerance to be
able to use their full potential for suppression of undesirable im-
mune activation.
Recent literature highlights cross-talk between cellular meta-
bolism and immune function (Odegaard et al., 2007; Tschopp,
2011). One example is metabolic syndrome, which is often asso-
ciated with chronic unregulated inflammation in various organs
(Odegaard et al., 2007; Tschopp, 2011). It is suggested that dys-
regulated production of reactive oxygen species (ROS) in mito-
chondria contributes to metabolic syndrome (James et al.,
2012). More than 30 years ago, the ability of isolated mitochon-
dria to produce the ROS H2O2 was demonstrated (Chance et al.,
1979). Subsequent studies showed that H2O2 is generated by
dismutation of superoxide by the action of a superoxide dismut-
ase (SOD) within mitochondria (Forman and Kennedy, 1974; Lo-
schen et al., 1974). These discoveries collectively established
mitochondria as an important source of cellular H2O2. Given
that mitochondria have emerged as important regulators of mul-
tiple cellular functions (Galluzzi et al., 2012), it seems equally
plausible that regulated mitochondrial ROS production contrib-
utes to immune homeostasis.
Peroxisome proliferator-activated receptor gamma (PPARg),
amember of the nuclear receptor superfamily, not only promotes
adipocyte differentiation and glucose homeostasis but also ex-
erts anti-inflammatory effects (Wahli andMichalik, 2012). PPARg
deletion in myeloid cells was shown to impair generation of alter-
natively activated macrophages and induce insulin resistance,)
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Inhaled Antigen-Activated PPARg Regulates Genes Involved in the Regulation of Inflammation and Fatty Acid Metabolism
(A) Schematic describes the 3-day OVA-exposure protocol for tolerance.
(B) ChIP assay of p19 and IL-6 promoters in Tol CD11c+ cells sorted from indicated conditions using anti-p65 and control antibodies is shown.
(legend continued on next page)
Cell Reports 15, 1700–1714, May 24, 2016 1701
suggesting a beneficial role of PPARg in controlling metabolic
diseases such as type 2 diabetes (Odegaard et al., 2007;
Tschopp, 2011). In the lung, PPARg is expressed by multiple
cell types including CD11c+ cells, which include the APC DCs
and macrophages (Belvisi et al., 2006). We recently reported
that conditional deletion of PPARg in the CD11c+ APCs in mice
induces an inflammatory response in the airways (Khare et al.,
2015). However, the molecular mechanism by which PPARg
expression in CD11c+ cells efficiently suppresses airway inflam-
mation despite constant provocation of the lungs by environ-
mental antigens remains poorly understood.
Hereweshow that, in theabsenceofPPARg, NF-kB is recruited
to thepromotersof thepro-inflammatory cytokinegenes, IL-6and
the p19 subunit of IL-23 in lung APCs, in keeping with increased
production of these cytokines in these cells (Khare et al., 2015).
Under tolerizing conditions, PPARg-sufficient CD11c+ cells dis-
played higher oxygen consumption rate (OCR) than PPARg-defi-
cient CD11c+ cells, which was sensitive to Cpt1 blockade. Using
two independent H2O2 detection methods, we identified H2O2 in
wild-type (WT), but not PPARg-deficient, cells from tolerized
mice, which involved mitochondrial Complex I, but not Com-
plex III, activity. PPARg was essential for increased SOD activity
in the cells. Forced restoration of H2O2 in PPARg-deficient cells
suppressed IkBa degradation. Conversely, use of a mitochondri-
ally targeted H2O2 scavenger, Mito-Tempo (Dikalova et al., 2010;
Murphy, 1997), promoted IkBadegradation, andairway tolerance
was replaced by an inflammatory response, as observed in mice
devoid of PPARg in CD11c+ cells (Khare et al., 2015). Taken
together, these findings establish a communication axis among
the nucleus, mitochondria, and the cell cytoplasm to prevent
unnecessary immune activation in the airways under conditions
of constant antigenic provocation.
RESULTS
Increased Recruitment of NF-kB to Promoters of
Pro-inflammatory Cytokine Genes in PPARg-Deficient
CD11c+ Cells and PPARg-Dependent Expression of
Genes Involved in Fatty Acid Metabolism
We recently reported that conditional deletion of PPARg in
CD11c+ cells, which include the APC DCs and macrophages
in the lungs, abolishes tolerance in the airways induced by
low doses of inhaled antigen with induction of inflammation,
although the underlying molecular mechanism was not
described (Khare et al., 2015). These CD11c-Cre+/-PPARgfl/fl
mice (referred to hereafter as PPARgDAPC mice) showed a mini-
mal change in the numbers of lung DCs as compared to the con-
trol PPARgfl/fl mice (referred to hereafter as WT mice), but they
showed enhanced expression of pro-inflammatory cytokine
genes under tolerizing conditions in all CD11c+ cells that(C) Heatmap representation of PPAR target array experiments for the indicated g
naive (lane 1), tolerized (lane 2), and ex vivo RSG-treated cells from WT mice (lan
(D) Graphical representation of relative expression in CD11c+ cells of indicated ge
SEMand are representative of two independent experiments (n = 3–4mice/group)
multiple groups; *p < 0.05, ***p < 0.001, and ****p < 0.0001 reflect comparisons to
comparisons with OVA tol PPARgfl/fl.
See also Figures S1, S2, and S3.
1702 Cell Reports 15, 1700–1714, May 24, 2016included CD103+ DCs, CD103 DCs, and macrophages (Khare
et al., 2015). Since NF-kB is a central regulator of expression
of pro-inflammatory cytokine genes (Hayden and Ghosh, 2008;
Pasparakis, 2009), we investigated whether deletion of PPARg
in CD11c+ cells aberrantly triggers NF-kB activation in response
to a low dose of inhaled antigen, which normally maintains
airway tolerance (Khare et al., 2013, 2015; Ostroukhova et al.,
2004). We used a shorter protocol for tolerance induction, which
involved exposure of the mice to 3 consecutive days of aerosol-
ized ovalbumin (OVA) (Figure 1A) instead of 10 days as previously
described by us (Khare et al., 2013, 2015; Ostroukhova et al.,
2004). Both protocols blunted induction of airway inflammation
to the same degree when tested for tolerance induction by sub-
sequently immunizing the mice with OVA plus adjuvant and then
repeatedly challenging by aerosolized OVA (Figure S1A). In both
protocols, we observed minimal recruitment of the p65 subunit
(Rel A) of NF-kB to the different NF-kB sites in the p19 and
IL-6 promoters in PPARg-sufficient cells, while p65 recruitment
was readily detectable when cells were PPARg deficient (Figures
1B and S1B).
Of note, in a study published recently in which PPARg was
similarly deleted in CD11c+ cells, a complete arrest in the
development of alveolar macrophages (AMs) characterized as
CD11c+CD11blo cells in bronchoalveolar lavage (BAL) and lung
cells was reported (Schneider et al., 2014). Instead, a significant
increase in CD11chi cells that were CD11bhi, autofluorescent,
and expressed F4/80 was noted; these cells were described
as AM-like cells (Schneider et al., 2014). Using a similar AM char-
acterization strategy, we found that, while CD11chiCD11bhi AM-
like cells are present in BAL and lung cells of PPARgDAPC mice
generated by us (Figure S2A), CD11c+CD11blo cells resembling
AMswere only reduced by50% in thesemice (Figure S2A), un-
like their complete absence in the PPARg conditional knockouts
described in the earlier study (Schneider et al., 2014). We then
focused on Siglec-F expression on CD11c+F4/80+ cells, the
co-expression of these molecules being restricted to only
macrophages in the lungs. We observed a slight reduction
in CD11c+F4/80+ cells in the lungs of PPARgDAPC mice as
compared to those in WT mice (Figure S2B). When gated on
these cells, 15% were CD11bhiSiglec-F+ cells in PPARgDAPC
mice as compared to 5% in WT mice with no downregulation
of Siglec-F expression in any subset, unlike what was observed
in the earlier study (Schneider et al., 2014). Thus, collectively, the
mice used by us had no difference in number of CD11c+ auto-
fluorescencelo DCs or CD11c+ autofluorescencehi macrophages
(AM and AM-like cells together) (Khare et al., 2015). The partial
reduction in AM numbers in the PPARgDAPC mice (Khare et al.,
2015) did not explain either the increase in expression of pro-
inflammatory cytokine genes in the CD11c+ cells derived
from these mice or the inability of these mice to support Tregenes clustered based on function. mRNA was isolated from CD11c+ cells from
e 3) and also from naive (lane 4) and tolerized PPARgDAPC (lane 5) mice.
nes in specific groups present in the PPAR target array. Data shown are mean ±
. One-way ANOVAwith Tukey’s post hoc test was used for comparisons among
expression in naive PPARgfl/fl and #p < 0.05 and ###p < 0.001 correspond to
Figure 2. Antigen-Activated PPARg Regu-
lates Fatty Acid Metabolism
(A) Total omega-3, omega-6, and saturated FFA
quantification (pmol/106 cells) as estimated by
GC-MS analysis performed on CD11c+ APCs and
CD11c B220 non-APCs sorted from the lungs
of naive WT mice. Data shown are composite of
three independent experiments and represent
mean values ± SEM.
(B) Presence of omega-3, omega-6, and saturated
FFAs in CD11c+ cells sorted from the lungs of
naive and tolerized WT and PPARgDAPC mice as
observed in two independent experiments, ex-
pressed as fold change (relative to naive of the
respective strain). Data shown are composite of
two independent experiments and represent mean
values ± SD.
(C) OCR of CD11c+ cells isolated from tolerizedWT
and PPARgDAPC mice was measured at the basal
level and then after sequential treatment with
DMEM/200 mMEto followed by 1 mMOligo, 1.5 mM
FCCP, and 0.1 mM Rot plus 1 mM Ant A using
the XF-96 Seahorse system. The assay is repre-
sentative of two independent experiments, run
in triplicates, and shown as mean values ± SEM
(*p < 0.05 and **p < 0.01).development in response to tolerance-inducing conditions
(Khare et al., 2015). Further, the increased presence of CD11bhi
macrophages in the lungs of the PPARg conditional knockout
mice suggested a shift in the population toward an activated
phenotype (Guth et al., 2009; Strı´z et al., 1993), as also was sug-
gested by the increased production of cytokines such as IL-6
and the p19 subunit of IL-23 by these cells (Khare et al., 2015).
Our next task was to determine how the presence of PPARg
blocks NF-kB recruitment to the promoters of cytokine genes
in CD11c+ cells. PPARg-mediated immune regulation requires
activation by either synthetic agonists like thiazolidinediones
(TZDs) or by endogenous ligands such as fatty acids. Our model
did not employ any synthetic ligand, and yet involvement of
PPARg in regulating the activation status of CD11c+ cells was
evident. Using a focused gene array, we compared the mRNA
expression profile of PPAR-regulated genes in the following
different sets of lung CD11c+ cells: those stimulated by the
TZD rosiglitazone (RSG) ex vivo, and those isolated from naive
or antigen (OVA)-tolerized (OVA-Tol) WT or PPARgDAPC mice
(Figures 1C, 1D, and S3). The enzymes Cpt1a and Cpt1b are
involved in fatty acid translocation across the mitochondrial
membrane, and expression of the former is typically higher in
immune cells (Wakil and Abu-Elheiga, 2009). The expression of
Cpt1a was significantly reduced in PPARg-deficient cells as
compared to that in WT cells (Figures 1C and 1D). Albeit ex-
pressed at a lower level, the relative increase in Cpt1b expres-
sion also was less in cells without PPARg (Figures 1C and 1D).
Fatty acid desaturase-2 (Fads-2) is an important enzyme that
catalyzes the generation of polyunsaturated fatty acids (PUFAs)
(Guillou et al., 2010). In response to inhaled antigen, the increase
in Fads2 expression was higher in WT cells as compared to
that in PPARg-deficient cells. As expected from previous publi-
cations, mRNA level of fatty acid-binding protein-4 (Fabp4)
increased several fold in RSG-treated cells (Odegaard et al.,2007), and the expression of helicase with zinc finger 2 (helz2),
which is a co-activator of PPARg and promotes optimal expres-
sion of Fabp4 (Katano-Toki et al., 2013), also was increased
(Figures 1C and 1D). The differential response of cells to inhaled
antigen versus RSG, both mediated by PPARg, suggested a
distinct molecular mechanism of PPARg action under conditions
of tolerance. Since Fabp4 binds and sequesters free fatty acids
(FFAs) in the cytoplasm of cells (Furuhashi and Hotamisligil,
2008), and its expression was not upregulated in the CD11c+
cells from tolerizedmice to the extent that it was upon RSG treat-
ment, we next examined the status of FFAs in the CD11c+ cells.
Lung CD11c+ cells as well as CD11c cells (minus B cells)
sorted from naive and tolerized WT and PPARgDAPC mice were
subjected to FFA analysis employing gas chromatography
coupled with mass spectrometry (GC-MS) (Figures 2A and 2B)
(Quehenberger et al., 2011). CD11c+ APCs from naive WT mice
contained significantly higher levels of free u-3 and u-6 PUFAs
compared to CD11c non-APCs, in which these FFAs were
barely detectable (Figure 2A). The levels of free saturated fatty
acids were, however, comparable between CD11c+ APCs and
CD11c non-APCs (Figure 2A). Under PPARg-sufficient condi-
tions, the levels of both u-3 and u-6 PUFAs were lower in
CD11c+ cells from tolerized mice as compared to cells from
naive mice, with the decrease in u-3 PUFAs reaching statistical
significance. However, the levels of saturated fatty acids were
similar in cells from naive and tolerized WT mice (Figure 2B).
In accordance with the gene expression data showing lower
Cpt1 expression in PPARg-deficient cells, there was no
decrease in u-3 and u-6 PUFAs in these cells isolated from to-
lerized PPARgDAPC mice (Figure 2B).
We next assessedOCR of CD11c+ cells isolated from tolerized
WT and PPARgDAPCmice. OCRwasmeasured at the basal level,
and then one batch of cells in both groups was treated with eto-
moxir (Eto) and then sequentially treated with oligomycin (Oligo),Cell Reports 15, 1700–1714, May 24, 2016 1703
carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP),
and rotenone plus antimycin (Ant A + Rot). Basal OCR inWT cells
was inhibited upon treatment with Eto, a specific inhibitor of
Cpt1 (Wolf and Brenner, 1988). PPARg-deficient CD11c+ cells
showed lower OCR overall as compared to PPARg-sufficient
cells, which was unchanged upon Eto treatment (Figure 2C).
The maximal OCR reached after FCCP injection of WT cells pre-
viously treated with Eto remained lower than those maintained
without Eto, suggesting fatty acid oxidation (FAO) to be an
important component of OCR in tolerizedWT cells. These results
suggested that conditions of tolerance or even basal conditions
that regulate immune homeostasis favor maintenance of a rela-
tively high level of endogenous PPARg ligands, such as PUFAs
in lung APCs, but not in non-APCs. Also, the lower levels of
free PUFAs in CD11c+ cells from tolerized WT mice combined
with higher Fads2 and Cpt1 expression together with higher
Eto-sensitive OCR in these cells suggested b-oxidation of fatty
acids in mitochondria with increased mitochondrial ROS pro-
duction in the cells.
Increased Mitochondrial H2O2 Production under
Conditions of Tolerance
The fact that PUFAs are not only ligands of PPARg but also are
substrates for mitochondrial electron transport (Lombardi
et al., 2008; Nethery et al., 2000) led us to examine the produc-
tion of ROS in lung CD11c+ cells. When generated in small quan-
tities via the mitochondrial electron transport chain (mETC)
(Chance et al., 1979), H2O2 has been shown to be important
for tissue homeostasis (Poole et al., 1997). Surprisingly, the
role of ROS in regulation of immune homeostasis, including acti-
vation of important transcription factors such as NF-kB under
physiological conditions, remains unclear. H2O2 is a diffusible
molecule and can be assayed in the extracellular medium by
the Amplex Red assay, a suitable method for quantitation of
H2O2 production (Kalyanaraman et al., 2012). H2O2 generated
in CD11c+ cells from tolerized PPARgfl/fl mice was greater
when compared to cells from naive mice (Figure 3A). Inhibition
of H2O2 generation in PPARg-sufficient CD11c
+ cells from toler-
ized mice by Rot, a specific inhibitor of mitochondrial complex I
(Figure 3A) (Lombardi et al., 2008; Murphy, 2009), but not by Ant
A, a specific inhibitor of complex III (Figure 3A) or L-NAME (NOS2
inhibitor) (Xia et al., 1996), confirmed the involvement of the
mETC in increasedH2O2 levels in response to antigen (Figure 3A).
Furthermore, inhibition by Rot suggested the involvement of
reverse electron transport (RET) in mitochondrial ROS genera-
tion (Murphy, 2009). In other studies in skeletal muscle cells,
mitochondrial H2O2 generation induced by PUFA (arachidonic
acid) also was inhibited by Rot (Lombardi et al., 2008). We also
observed that PPARg-sufficient CD11c+ cells treated with RSG
did not generate H2O2 (Figure 3A), which reaffirmed that RSG-
mediated and low-dose antigen-mediated PPARg activation
induce different responses in the CD11c+ cells. Figure 3A shows
specificity of themETC inhibitors with selective inhibition of com-
plex I by Rot and of complex III by Ant A (Shiva et al., 2007).
We next assessed whether the increase in H2O2 production
from CD11c+ cells from tolerized WT mice depends on PPARg,
which was found to be the case (Figure 3B). Essentially, similar
results were obtained by imaging when the boronate compound1704 Cell Reports 15, 1700–1714, May 24, 2016peroxyfluor-6 acetoxymethyl ester (PF6-AM), a selective fluores-
cent detector of H2O2 (Basu et al., 2014; Dickinson et al., 2011;
Lin et al., 2013), was used with H2O2 readily detected in
CD11c+ cells from WT, but not PPARg-deficient, cells (Fig-
ure 3C). Similar results were obtained when the mice were
exposed to a different allergen, Derp1, of house dust mite (Cates
et al., 2004) (Figure 3C), demonstrating the generality of the ef-
fect of PPARg deficiency in CD11c+ cells on H2O2 generation
in the cells. The results described above raised the question of
how PPARg promotes H2O2 generation in the CD11c
+ cells.
Cellular H2O2 is generated following dismutation of superoxide
radical generated during mitochondrial electron transport by
SOD enzymes (Buettner, 2011). The expression of bothMnSOD
(SOD2), which is targeted to mitochondria, and of CuZnSOD
(SOD1), which is cytosolic, at both mRNA and protein levels,
was reduced in PPARg-deficient cells compared to WT cells
(Figure 3D). PPARg-sufficient, but not PPARg-deficient,
CD11c+ cells showed increased SOD activity (Figure 3E).
PPARg-induced SOD activity under tolerizing conditions in WT
cells can, therefore, be expected to cause an increase in cyto-
solic H2O2 level due to diffusion of H2O2 across themitochondrial
membrane (Brand, 2010).
We next examined the morphology of mitochondria in CD11c+
cells derived from naive and tolerized WT and PPARgDAPC mice
by staining the mitochondrial membrane with Tom20. Mitochon-
dria are extremely dynamic organelles that fragment and fuse
continuously; the morphology of mitochondria (fragmented
versus extensive fused networks) strongly influences function
(da Silva et al., 2014). Mitochondrial abundance was measured
using confocal microscopy followed by three-dimensional
surface rendering and calculation of mitochondrial volume
(abundance). Mitochondrial fragmentation was assessed using
the sphericity parameter. The closer the sphericity value is to
1, the more spherical and fragmented the mitochondria. The
average sphericity in our samples was low, ranging around 0.5,
indicating that the mitochondria were highly networked. Both
volume and sphericity calculations showed no difference
whether cells were examined from WT or PPARg-deficient cells
(Figures 3F and S4). Similar data were obtained by quantifying
the mtDNA copy number in WT and PPARg-deficient cells (Fig-
ure 3G). These observations ruled out a difference in mitochon-
drial abundance or health between theWT and PPARgDAPC mice
as contributing to the increased inflammatory phenotype of the
latter and instead focused our attention on regulation of gene
expression by H2O2.
PPARg Prevents NF-kB Activation in Tolerized Mice
The physiological relevance of the effects of high concentrations
of H2O2 on NF-kB activation in vitro is difficult to ascertain
without in vivo supportive evidence (Oliveira-Marques et al.,
2009). Unlike most studies that have shown mild NF-kB activa-
tion in response to large doses of H2O2 (Oliveira-Marques
et al., 2009), one prior study using mouse alveolar epithelial cells
showed that H2O2 can inhibit NF-kB activation by limiting IKK
phosphorylation (Korn et al., 2001). Consistent with this finding,
we observed greater IKK phosphorylation in tolerized PPARg-
deficient CD11c+ cells compared to PPARg-sufficient cells (Fig-
ure 4A), the former having lower H2O2 levels (Figures 3B and 3C).
Figure 3. PPARg Expression Regulates Mitochondrial ROS Generation
(A) Amplex Red assay was used to quantitate H2O2 generation in sorted lung CD11c
+ cells from naive WT mice in the presence or absence of RSG (10 mM) and
tolerized WT mice in the presence or absence of Rot (10 mM), Ant A (100 mM), or L-NAME (50 mM). Complex I and complex III activities were measured to assess
specificity and dose efficiency of Rot and Ant A, respectively.
(B) Quantification of H2O2 generation in sorted lung CD11c
+ cells from naive and tolerized WT and PPARgDAPC mice. Data for (A) and (B) represent one of three
independent experiments and are shown as mean ± SEM.
(legend continued on next page)
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IKK mediates phosphorylation of specific Ser residues in IkBa,
leading to ubiquitination and proteasomal degradation (reviewed
in Karin and Ben-Neriah, 2000). In accordance with the IKK
phosphorylation data, a lower expression level of IkBa in the
cytoplasmic extracts of PPARg-deficient CD11c+ cells was
found as compared to that in control CD11c+ cells. In lung
CD11c cells, in which PPARg was not deleted, the level of
IkBa was comparable between PPARgDAPC and WT mice (Fig-
ure 4A). Conversely, a higher expression of c-rel and the p65
subunit of NF-kB (RelA) was observed in the nuclear extracts
of PPARg-deficient CD11c+ cells when compared to control ex-
tracts (Figure 4B). Similar observations were made when mice
were exposed to Derp1 (Figure 4C), demonstrating the generality
of effect of PPARg deficiency in CD11c+ cells on NF-kB activa-
tion. Both chymotrypsin-like and trypsin-like proteasomal activ-
ities were similar in CD11c+ cells from PPARgDAPC and WT mice
irrespective of whether cells were isolated from naive or OVA-
exposed mice (Figure S5A), ruling out a difference in proteaso-
mal activity between PPARg-sufficient and PPARg-deficient
cells as playing any role in differential NF-kB activation in these
cells.
If PPARg-dependent H2O2 generation indeed inhibits phos-
phorylation of IkBa, we hypothesized that incubation of
PPARg-deficient CD11c+ cells with 2,3-dimethoxy-1,4-naphtho-
quinone (DMNQ), a non-thiol-capturing and non-alkylating
redox-cycling quinone that causes continuous intracellular gen-
eration of H2O2 (Parry et al., 2009), would reverse the effects on
IkBa. Importantly, forced generation of H2O2 using DMNQ does
not require SOD, which provided an opportunity to bypass
PPARg. Indeed, DMNQ treatment resulted in increased intracel-
lular H2O2 levels (Figure S5B), reducing pIkBa and increasing
IkBa levels compared to untreated cells (Figure 4D). DMNQ
caused a similar differential in pIkBa and IkBa, albeit lower in
magnitude, in cells from tolerized WT mice that, to begin with,
harbored a higher level of H2O2 (Figure 4D). Correspondingly,
reduced nuclear translocation of p65 was observed in DMNQ-
treated cells compared to untreated cells (Figure 4D).
To further investigate a causal relationship between reduced
H2O2 and heightened NF-kB activation in the CD11c
+ cells,
we co-cultured CD11c+ DCs from tolerized CD11c-specific
PPARg-deficient and -sufficient mice with carboxyfluorescein
succinimidyl ester (CFSE)-labeled Treg-depleted OT-II CD4+
T cells in the presence of OVA peptide, and we assessed T cell
proliferation. The PPARg-deficient cells induced better T cell
proliferation compared to WT cells, as determined by quantita-(C) Intracellular H2O2 detection in sorted lung CD11c
+ cells from tolerizedWT and P
with PF6-AM, OVA (10 mg/ml) or Derp 1 (0.5 mg/ml) was included. In the absence o
WT cells and none detected in the PPARg-deficient cells (data not shown). As
in vitro ± catalase (10 mM). Representative immunofluorescence images (left) and
field (five to six fields chosen randomly using DAPI as a guide and then assesse
graphs show data as mean values ± SEM.
(D and E) LungCD11c+ cells from tolerizedWT and PPARgDAPCmicewere analyze
panel) and (E) SOD activity. Data are shown as mean values ± SD.
(F) Representative immunofluorescence images (left) and sphericity and mitocho
(green), DAPI (blue), and phalloidin (red) are shown. Scale bar, 10 mm; magnifica
(G) Quantification of mtDNA and nuclear DNA (nDNA) in purified lung CD11c+ cell
represent one of two independent experiments and are shown as mean values ± S
See also Figure S4.
1706 Cell Reports 15, 1700–1714, May 24, 2016tion of the percentage of CFSE+ cells in each population of
divided cells (Figure 5A). T cell proliferation induced by the
PPARg-deficient CD11c+ cells was drastically inhibited by pre-
treatment of the DCswith the specific inhibitor of IkBa phosphor-
ylation, BAY 11-7082 (Figures 5B and S6). A significant decrease
in the level of IL-2 also was observed in co-cultures stimulated
with DCs pre-treated with BAY-117082 (Figure 5C).
Scavenging Mitochondrial ROS Promotes NF-kB
Activation and Impairs Airway Tolerance
To further confirm the specific role of mitochondrial ROS in
the suppression of NF-kB activation, we made use of the mito-
chondrially targeted ROS scavenger Mito-TEMPO (Dikalova
et al., 2010; Murphy, 1997). As shown in Figure 6A, use of
Mito-TEMPO reduced H2O2 production from the CD11c
+ cells
isolated from C57/BL6J tolerized mice. Next we used Mito-
TEMPO in vivo to demonstrate the importance of mitochondrial
ROS in blocking NF-kB activation and expression of pro-inflam-
matory cytokine genes during tolerance, thereby favoring Treg
generation and immune suppression. Mito-TEMPO was instilled
into mice using an osmotic pump and exposed the mice to
aerosolized OVA. Lung CD11c+ cells isolated from mice that
received Mito-TEMPO showed a higher level of pIkBa and a
lower level of IkBa as compared to those that received saline
(Figure 6B). While the results of these experiments do not
exclude a role for other cellular superoxide-generating systems
(including NADPH oxidase), in aggregate, our data demonstrate
that mitochondrially derived H2O2 contributes significantly to
NF-kB inhibition.
Since Foxp3 induction in adoptively transferred naive CD4+
T cells is severely impaired in CD103 DC-deficient Batf3/
mice (Khare et al., 2013), we asked whether quenching of mito-
chondrial ROS by Mito-TEMPO in vivo, which would cause
NF-kB activation in all DCs including CD103+ DCs, would simi-
larly affect Foxp3 induction in naive CD4+ T cells. Treatment
with Mito-TEMPO blunted Foxp3 induction in adoptively
transferred CD4+CD25 T cells from OT-IIxThy1.1 mice (Fig-
ure 6C). Conversely, we detected increased expression of the
pro-inflammatory cytokine IL-23p19 (Figures 6D and 6E) in
CD103+ DCs isolated from Mito-TEMPO-treated tolerized mice
compared to controls. Compared to vehicle-treated controls, to-
lerized mice that received Mito-TEMPO showed a significant
increase in neutrophil infiltration and a smaller increase in eosin-
ophil infiltration in the airways when challenged in the inflamma-
tion model (Figure 6F). The accompanying CD4+ T cell responsePARgDAPCmice using the H2O2-specific probe PF6-AM. During the incubation
f antigen in vitro, a similar profile was obtained with lower signal intensity in the
a positive control, exogenous H2O2 (100 mM) was added to the CD11c
+ cells
fluorescence quantification (right) represent cytosolic H2O2 signal per cell per
d for PF6-AM-specific signal). Scale bar, 100 mm and magnification 203. Bar
d for (D)MnSOD andCu/ZnSODmRNA (left panel) and protein expression (right
ndrial volume/cell estimation (right) of lung CD11c+ cells stained with Tom20
tion 603.
s from naive and tolerized WT and PPARgDAPC mice. Data in panels (F) and (G)
D. ND, not detected; NS, not significant; *p < 0.05, ***p < 0.001, ****p < 0.0001.
Figure 4. Absence of Mitochondrial ROS Promotes NF-kB Activation
(A–D) Representative western blot and densitometry quantification to detect expression of (A) phospho IKKa/IKKb levels in sorted CD11c+ cells; (B) IkBa in
cytoplasmic extracts and c-rel, p65 subunit (RelA) of NF-kB in nuclear extracts prepared from lung CD11c+ and CD11c cells from PPARgDAPC andWTmice 1 hr
after the last exposure to OVA; (C) IkBa in lung CD11c+ cells sorted from PPARgDAPC and WT mice 1 hr after the last exposure to Derp1; and (D) phospho IkBa
(pIkBa) and total IkBa levels in whole-cell extract and p65 levels in nuclear extracts from lung CD11c+ cells (sorted from tolerized mice), cultured for 1 hr in the
presence or absence of DMNQ (200 mM). For all western blot analyses, expression of b-actin and LSD1 is shown as loading controls for cytoplasmic and nuclear
extracts, respectively, and densitometric quantification is combined data from two independent experiments represented as mean ± SD. ND, not detected;
*p < 0.05, **p < 0.01.
See also Figure S5.showed a prominent increase in IL-17 expression accompanied
by an increase in IFN-g expression (Figure 6G). Therefore, results
obtained with Mito-TEMPO treatment of mice were in close
agreement with those derived using PPARgDAPC mice (Khare
et al., 2015), thereby demonstrating that a major mechanism
by which PPARg regulates immune tolerance is by controlling
mitochondrial ROS generation.
DISCUSSION
Our study highlights a previously unappreciated function of
PPARg in regulating immune tolerance induced by low doses
of inhaled antigen by invoking mitochondrial metabolism inlung APCs. We show that PPARg prevents nuclear translocation
of NF-kB, limiting binding to target sites in the promoters of pro-
inflammatory cytokine genes. Use of a targeted gene array re-
vealed differential expression of enzymes involved in mitochon-
drial FAO between WT and PPARg-deficient cells. PPARg was
required for optimal Cpt1a and Cpt1b mRNA expression in
CD11c+ cells, Cpt1 proteins being required for FFA translocation
to mitochondria. PPARg also promoted expression of Fads2 in
response to inhaled antigen, Fads-2 being shown to catalyze
de novo generation of PUFAs.We show that the OCR ofWT cells
from tolerized mice is inhibited by blockade of Cpt1 and is
substantially reduced in the absence of PPARg. We provide
evidence of mitochondrial respiration involving complex I forCell Reports 15, 1700–1714, May 24, 2016 1707
Figure 5. Absence of PPARg in CD11c+ DCs
Promotes T cell Proliferation via NF-kB
Activation
CFSE-labeled Treg-depleted OT-II splenic CD4+
T cells were stimulated with either vehicle or BAY11-
7082 (10 mM) pre-treated CD11c+ DCs sorted from
tolerized PPARgDAPC and WT mice.
(A) T cell proliferation was assessed after 72 hr by
estimating CFSE dilution using flow cytometry, and
number of cells per generation was calculated.
(B) Overlay plot showing T cell proliferation as CFSE
dilution when stimulated in presence of either
vehicle or BAY11-7082 (10 mM) pre-treated CD11c+
DCs sorted from tolerized PPARgDAPC mice. Data
shown are representative of three independent
experiments.
(C) Expression of IL-2 was assessed in the
PPARgDAPC DC-T cell co-culture supernatant by
ELISA. Data for (A) and (C) are shown as mean
values ± SEM and composite of three independent
experiments. *p < 0.05, ***p < 0.00.
See also Figure S6.increased H2O2 generation in response to inhaled antigen in WT
cells, which inhibited IkBa phosphorylation/NF-kB activation in
these cells. It is interesting to note that mitochondrial complex
III activity causing increased ROS generation has been associ-
ated with IL-2 production and NF-AT activation in T cells (Sena
et al., 2013). Loss of PPARg in the CD11c+ cells led to undetect-
able SOD activity, explaining reduced H2O2 generation in the
cells. Scavenging of mitochondrial ROS induced IkBa phosphor-
ylation and promoted expression of cytokine genes, which
favored T helper responses and inhibited Treg development
with the loss of immune tolerance.
Our gene expression data and FFA analyses collectively sug-
gest that an important task of PPARg is to promote mitochon-
drial oxidation of PUFAs in lung APCs. It is important to note
that, in the CD11c+ cells during inflammation, we have detected
lower expression of PPARg (Khare et al., 2015). Thus, although
PUFAs are present in CD11c+ cells under conditions of inflam-
mation (data not shown), lower levels of PPARg translating into
lower SOD activity would prevent an increase in H2O2 level in
these cells, promoting NF-kB activation. The relevance of
weak NF-kB activation by H2O2 observed in in vitro studies by
treating cell lines with H2O2 or by using antioxidants such as1708 Cell Reports 15, 1700–1714, May 24, 2016N-acetyl cysteine (NAC) or pyrrolidine
dithiocarbamate (PDTC) has been a sub-
ject of considerable debate (Oliveira-Mar-
ques et al., 2009). The positive effect of
H2O2 on NF-kB activation observed in
these studies has been largely cell type
dependent, and, in some studies, it
showed no evidence of IkBa degradation
but instead involved tyrosine phosphoryla-
tion and dissociation of IkBa from NF-kB
(Be´raud et al., 1999). Also, reassessment
of the effects of NAC and PDTC showed
that they attenuated NF-kB activation inde-
pendent of their antioxidant function.Limited information exists about the role of H2O2 in the im-
mune system. Our data show that PPARg-deficient CD11c+ cells
from antigen-exposed mice have undetectable SOD activity and
a lower H2O2 level. A peroxisome proliferator-response element
(PPRE) was identified previously in the promoter of the
CuZnSOD gene (Yoo et al., 1999). In addition, cardiac PPARg
was shown to be important for the expression of MnSOD (Ding
et al., 2007). An increase in mitochondrial H2O2 level mediated
by PPARg-promoted SOD activity would result in increased
cytosolic H2O2 level due to free diffusion of H2O2 across the
mitochondrial membrane, resulting in phosphorylation and ulti-
mately degradation of IkBa. Interestingly, SOD inactivation has
been associated with asthma pathophysiology (Comhair et al.,
2005). Our study suggests that, under ambient levels of expo-
sure to environmental antigens, the PPARg-dependent increase
in H2O2 serves a prophylactic function by blocking NF-kB activa-
tion and its nuclear translocation, thereby preventing its recruit-
ment to cytokine promoters. However, we propose that, with the
use of next-generation TZDs with minimum side effects, PPARg
also can be utilized therapeutically, once inflammation is
induced and NF-kB is recruited to target promoters where trans-
repression functions of PPARg involving PPARg SUMOylation
Figure 6. Absence of PPARg-Dependent Mitochondrial ROS Generation in CD11c+ Cells Induces a TH1/TH17 Immune Response
Osmotic pumps delivering either saline or Mito-TEMPO (0.7 mg/kg/day) were surgically inserted in C57/BL6J mice that were then exposed to inhaled OVA (as
indicated).
(A) Amplex Red assay was used to quantitate H2O2 generation in sorted lung CD11c
+ cells. Combined data from two independent experiments are expressed as
mean ± SEM.
(B) Representative western blot and densitometry quantification to detect expression of pIkBa and total IkBa levels in lung CD11c+ cells are shown.
(legend continued on next page)
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can be exploited (Pascual et al., 2005). Taken together, diverse
mechanisms can be utilized by PPARg to exercise its anti-inflam-
matory effects, which also may depend on the specific ligand
engaged by this nuclear receptor.
In summary, our study demonstrates a protective role of
mitochondria in CD11c+ cells as a source of beneficial H2O2,
the generation of which requires PPARg. In various capacities,
mitochondria are now considered master regulators of danger
signaling (Galluzzi et al., 2012). While immune tolerance is
desirable to blunt allergic and autoimmune diseases, it is an
undesirable outcome in cancer that prevents anti-tumor im-
mune responses. In general, oxidative stress is associated with
deleterious consequences including tumorigenesis (Finkel,
2003). High levels of H2O2 are associated with many cancers (Li-
santi et al., 2011), which, based on the results of the present
study, may promote Treg cells that impair anti-cancer immunity.
Targeting mitochondria by specific small molecules (Murphy,
1997) to either promote or quench H2O2 production may provide
therapeutic benefit to blunt inflammatory diseases, like asthma
and various autoimmune diseases, or to induce anti-tumor
immunity.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6J (00664), PPARgfl/fl (004584), andCD11c-Cre+/ (008068) mice were
purchased from The Jackson Laboratory and were housed in the Department
of Laboratory Animal Resources (DLAR) at the University of Pittsburgh.
PPARgfl/fl and CD11c-Cre+/ mice were bred to generate mice with deletion
of PPARg in CD11c+ cells (CD11c-Cre+/-PPARgfl/fl) and littermate controls
(PPARgfl/fl) (Khare et al., 2015).CD11c-Cre+/mice also were used as controls
and were found to be functionally similar to PPARgfl/fl mice (data not shown).
OT-IIxThy1.1 transgenic mice, a gift from Dr. Lauren Cohn at Yale University,
were bred in the DLAR facility. All mice were housed under pathogen-free con-
ditions and used between 6 and 12weeks of age. All protocols involving animal
experiments were approved by the Institutional Animal Care and Use Commit-
tee (IACUC) at the University of Pittsburgh.
Exposure of Mice to Antigens to Induce Tolerance and Assessment
of Airway Inflammation
The mice were exposed to aerosolized OVA for 3 consecutive days and lung
cells were harvested 1 hr after the last exposure, as shown in Figure 1A. For
comparison of tolerance models, mice were tolerized by exposure to OVA
for 10 consecutive days, as described before (Ostroukhova et al., 2004). In ex-
periments where mice were exposed to the allergen Derp1 of house dust
mites, 20 ml LoTox Natural Derp1 protein (nDerp 1, Indoor Biotechnologies) re-
suspended in PBS at a concentration of 1mg/ml was intranasally administered
once for 3 consecutive days. For assessing the role of ROS in the induction of
tolerance versus pro-inflammatory cytokines, mini-osmotic pumps (Alzet(C) 106 CD4+CD25 splenic T cells fromOT-IIxThy1.1micewere adoptively transfe
inhaled OVA (upper left panel), and Foxp3 induction in the donor T cells in the lung
one of two experiments (bottom left) and frequency (top right) and number (bot
represent individual mice (n = 6); horizontal lines show the mean values and erro
(D) Expression of Il23a (p19) mRNA in CD103+ CD11c+ lung cells sorted from naive
(E) Flow cytometry analysis (left) and frequency (right) of IL-23p19-expressing lung
mice. Symbols in the graphs represent individual mice (n = 3); horizontal lines sh
(F and G) Following osmotic pump implantation, mice were tolerized to OVA and
Then 24 hr after the last treatment, various parameters of inflammation were an
BAL fluid; and (G) numbers of total lung cells, CD4+ T cells, and IL-17A+ and IF
enumerated. Symbols in the graphs represent individual mice (n = 5); horizontal lin
***p < 0.001).
1710 Cell Reports 15, 1700–1714, May 24, 2016model 2001, 1 ml/hr, 7 days and OR Alzet model 2002, 0.5 ml/hr, 14 days), con-
taining either Mito-TEMPO (0.7 mg/kg/day) or saline, were subcutaneously in-
serted into WT mice under anesthesia. The mice were then subjected to aero-
solized OVA for 20 min each day over a 3-day or a 10-day period (McMenamin
et al., 1994; Ostroukhova et al., 2004). To test for induction of tolerance, the
tolerized mice were subjected to an inflammation model as previously
described by us involving intranasal administration of OVA along with the adju-
vant cholera toxin (CT, List Biochemicals) (Khare et al., 2013, 2015; Oriss et al.,
2005). Mice were challenged with aerosolized OVA daily for the next 7 days.
The degree of airway inflammation and/or resistance to antigen challenge
(tolerance) was assessed in mice 24 hr following completion of the protocol(s)
outlined in the preceding section, as described previously (Khare et al., 2013;
Krishnamoorthy et al., 2012; Oriss et al., 2005).
Cell Isolation and Sorting
The lungs of euthanized mice were perfused with sterile PBS, dissected, and
enzymatically digested as described previously (Khare et al., 2013, 2015; Oriss
et al., 2005). Lung cells were then physically dissociated on a gentleMACSDis-
sociator (Miltenyi Biotec) according to the manufacturer’s protocol. Single-cell
suspensions were obtained by passing the dissociated tissue through a 70-mM
cell strainer (BD Falcon). Magnetic separation utilizing anti-CD11cmicrobeads
(Miltenyi Biotec) was used to enrich for CD11c+ cells. The lung CD11c+ cells
were sorted into CD11c+ DCs (low auto-fluorescence) to greater than 90% pu-
rity using a FACSAria cell sorter (BD Immunocytometry Systems) for DC-T cell
co-culture.
Antibodies and Flow Cytometry
Cell-surface markers were analyzed on several cell types using a variety of re-
agents. Cells were stained in 13 PBS containing 2% (w/v) fetal bovine serum
(FBS) with anti-CD4-APC or PE-Cy7 (RM4-5, BD Biosciences); anti-CD11c-
APC, PercP-Cy5.5, PE-Cy7 (HL3, BD Biosciences); anti-CD103-PE (M290,
BD Biosciences); anti-CD11b-PE-Cy7, PE-CF594 (M1/70, BD Biosciences);
anti-CD90.1-PE (OX-7, BD Biosciences); anti-MHCII FITC (NIMR4, Southern
Biotech); anti-CD45-PE-Cy7 (30F11, Biolegend); anti-Siglec-F-PE, PE-
CF594 (E50-2440, BD Biosciences); and anti-F4/80-Alexa fluor 647, PE
(BM8, Invitrogen). Intracellular staining was performed according to the man-
ufacturer’s instructions. Intracellular staining with anti-IL-17A-PE (eBio17B7,
eBioscience) and anti-IFN-g-FITC (XMG1.2, BD Biosciences) was assessed
in cells stimulated for a total of 6 hr with PMA (50 ng/ml, Sigma) and ionomycin
(1 mg/ml, Sigma) in the presence of monensin (BD Biosciences) for the final 3 hr
of incubation, according to the manufacturer’s instructions (BD Biosciences).
For intracellular cytokine staining in DCs, lung cells were cultured ex vivo in the
presence of monensin alone for 5 hr and stained with anti-IL-23p19-efluor 660
(fc23cpg, eBioscience), according to the manufacturer’s instructions. Stained
cells were examined on FACSCalibur and FACSAria flow cytometers (BD
Immunocytometry Systems), and the data were analyzed using FlowJo
software (Tree Star).
Induction of Foxp3+ CD4+ T Cells In Vivo
Treg-depleted CD4+ T (CD4+CD25) cells were isolated from OT-IIxThy1.1
spleens as described before (Khare et al., 2015; Krishnamoorthy et al.,
2012), and they were adoptively transferred intravenously (106 cells perrred following osmotic pump implantation. The recipientmicewere exposed to
s of the recipient mice was assessed. Representative flow cytometry data from
tom right) of CD4+ Thy1.1+ Foxp3+ T cells are shown. Symbols in the graphs
r bars denote SEM.
and tolerized saline- or Mito-TEMPO-treated mice, relative to hprt1, is shown.
CD103+CD11c+ cells from naive and tolerized saline- or Mito-TEMPO-treated
ow the mean values and error bars denote SEM.
tested for induction of tolerance as described in the Experimental Procedures.
alyzed. (F) Total cell numbers (left); eosinophils and neutrophils (right) in the
N-g+ CD4+ T cells in the lungs of saline- or Mito-TEMPO-treated mice were
es show the mean values and error bars denote SEM (*p < 0.05, **p < 0.01, and
recipient) intoCD11c-Cre+/-PPARgfl/fl (PPARgDAPC) andPPARgfl/fl (WT) mice,
respectively. Then 24 hr following the adoptive transfer of cells, the recipient
mice were exposed to OVA aerosols for 10 consecutive days and sacrificed
1 day following the last challenge. PBS-perfused lungs were harvested and
single-cell suspensions were prepared. In vivo induction of Foxp3 was as-
sessed by staining for donor mouse strain-specific cell-surface marker anti-
CD90.1 along with anti-CD4 and anti-Foxp3. CD4+ T cells positive for donor
cell-surface marker were selected for analysis of Foxp3 expression.
RNA Isolation and qRT-PCR or Semiquantitative RT-PCR
Sorted lung CD11c+ cells from CD11c-Cre-PPARgfl/fl and PPARgfl/fl mice were
lysed using RLT plus Buffer (QIAGEN), and RNA was extracted using an
RNeasy Plus Micro kit (QIAGEN) according to the manufacturer’s instructions.
cDNAwas synthesized using a High-Capacity cDNA Reverse Transcription Kit
(Life Technologies) and was used as a template for qPCR according to the
manufacturer’s instructions (Life Technologies). Primer and probe sets for as-
saying individual gene expression were purchased from Life Technologies
(Taqman Gene Expression Assays). The qRT-PCR reactions were carried
out using the ABI PRISM 7700 Sequence System (Applied Biosystems) at
the Genomics Research Core at the University of Pittsburgh. Results were
analyzed using the SDS 2.2.2 software. The mRNA expression was calculated
using the 2DCt method with hprt1 as internal reference control.
PPAR Target PCR Array
Lung CD11c+ cells were sorted from naive or tolerized (OVA-exposed) WT and
PPARgDAPC mice. CD11c+ cells isolated from naive WTmice were treated with
either vehicle or 10 mMRSG in vitro for 4 hr at 37C. Total RNA was isolated as
described above and subjected to cDNA synthesis using RT2 First Strand Kit
(QIAGEN). Gene expression from four biological replicates was analyzed
using RT2 Profiler PCR Array Mouse PPAR Targets (PAMM-149Z, QIAGEN)
according to the manufacturer’s instructions. Data analysis was carried out
using web-based analysis software available on QIAGEN’s website. A heat-
map was generated using the HeatMapImage module available at http://
genepattern.broadinstitute.org.
CFSE Proliferation Assay
Treg-depleted splenic CD4+ T cells from OT-II mice were labeled with CFSE
(Vybrant CFDA-SE cell tracer kit, Invitrogen). Briefly, CD4+ CD25 T cells
were labeled with 5 mM CFSE for 10 min at 37C and co-cultured in the
presence of 1 mg/mL OVA-peptide, with CD11c+ DCs sorted from tolerized
PPARgDAPC and WT mice that were pre-treated for 1 hr at 37C with either
vehicle or 10 mM BAY11-7082 (EMD Millipore) at a DC:T cell ratio of 1:10.
CD4+ T cell proliferation was assessed after 72 hr using flow cytometry. IL-2
level in culture supernatants was assessed by ELISA.
GC-MS Analysis for FFAs
CD11c+ and CD11c cells isolated from the lungs of naive and tolerized WT
and PPARgDAPC mice were frozen at 80C under inert condition and sent
to Lipid Maps, Lipidomics Core (University of California, San Diego) for assay-
ing concentrations of FFAs using GC-MS (Quehenberger et al., 2011). For the
analysis of FFAs, the biological material was supplemented with a cocktail of
deuterated internal fatty acid standards and extracted twice with 0.05 N
methanolic HCl/isooctane (1:3, v/v), and the combined isooctane layers
were evaporated to dryness. The extracted FFAs were derivatized with penta-
fluorobenzyl bromide, and the fatty acid esters were analyzed byGC-MS on an
Agilent 6890N gas chromatograph equipped with an Agilent 5973 mass selec-
tive detector (Agilent). Fatty acid quantitation was achieved by the stable
isotope dilution method using concentration curves generated from fatty
acid quantitative standards using identical conditions. The raw data obtained
then were subjected to analysis and the unknowns compared to the standard
curves generated and represented as pmol/106 cells.
Western Blot Analysis
Total cell lysates and nuclear and cytoplasmic extracts were prepared from
sorted and/or treated CD11c+ and CD11c cells as described in the text using
lysis buffer (Cell Signaling Technology) and nuclear extraction kit (Panomics),
respectively. Lysates (15 mg) were separated on 10% SDS-PAGE gels andthen transferred onto polyvinylidene fluoride (PVDF) membranes (Millipore).
Nonspecific binding was blocked by incubation in blocking buffer (5% nonfat
milk in Tris-buffered saline with Tween [TBST]), followed by sequential incuba-
tions with the primary antibody and appropriate horseradish peroxidase-
conjugated secondary antibody (Thermo Scientific), each diluted in blocking
buffer. Immunoreactive protein was detected using enhanced chemilumines-
cence (ECL) reagents (Thermo Scientific). Antibodies against IkBa (Santa Cruz
Biotechnology), phospho-IkBa, NF-kB subunit p65, c-rel, LSD1 (Cell Signaling
Technology), phospho IKKa/b, IKKa/b (Cell Signaling Technology), MnSOD
(EMD Millipore), Cu-ZnSOD (Enzo Life Sciences), and b-actin (Cell Signaling
Technology) were used for western blot analysis. Densitometric analysis was
performed using the ImageJ software.
Chromatin Immunoprecipitation Assay
Chromatin immunoprecipitation (ChIP) assays were done according to the
manufacturer’s protocol (Pierce) with slight modifications. In brief, CD11c+
cells sorted from the lungs of tolerized (3-day or 10-day model) WT and
PPARgDAPC mice were fixed with 1% formaldehyde, quenched using 1 M
glycine, lysed, and chromatin digested using ChIP grade Micrococcal
Nuclease for 15 min at 37C. Each pull-down was performed using 0.3 3 106
cells with anti-PPARg (Abcam) using Protein A/G beads. Beads were washed
with high-salt and lithium chloride-containing buffers. Chelex-100 Resin was
added directly to the beads, and the beads were heated to 95C for 10 min
and incubated at 55C with Proteinase K. Samples were heated again and su-
pernatants collected were used for PCR with the following ChIP primers: IL-6
(60 bp) (forward 50-CCCACCCTCCAACAAAGATT-30 and reverse 50-TGAG
CTACAGACATCCCCAGT-30), p19 (153 bp) (forward 50-GGAACTGAAGCG
GCATACCT-30 and reverse 50-AAGGTCCCTGCACTGTAAGG-30 ), and p19
(123 bp) (forward 50-AGGTGATCTAAGAAGGTGGCT-30 and reverse
50-TTCGAAGTCTGGTTCCCGTG-30). The primers and the respective binding
sites were designed and validated using Cold Spring Software’s NCBI Primer
Blast and Match-1.0.
Chymotrypsin- and Trypsin-like Protease Activity
Lung CD11c+ cells were sorted from 3-day tolerizedWT and PPARgDAPCmice,
and chymotrypsin-like and trypsin-like activities associated with the protea-
some complex were measured from 10,000 cells/well using a homogeneous,
luminescent Proteasome-Glo Cell-Based Assay (Promega) according to the
manufacturer’s instructions. The plates were read on Veritas microplate lumin-
ometer (Turner Biosystems).
SOD Activity
Extracts from lung CD11c+ cells sorted from tolerized WT and PPARgDAPC
micewere prepared and assayed for SOD activity using a colorimetric SOD ac-
tivity kit (Cayman Chemicals), according to the manufacturer’s instructions.
Detection of ROS
Intracellular H2O2 level in CD11c
+ cells from naive, in the presence or absence
of RSG (1 hr at 37C), tolerized WT and PPARgDAPC mice (1 hr after the last
exposure to inhaled allergen) in the presence or absence of Rot, L-NAME, or
Ant A (Sigma) and from WT mice treated with either saline or Mito-TEMPO,
administered through mini-osmotic pumps (naive and OVA tolerized), was as-
sessed by Amplex Red assay. For intracellular detection of H2O2, lung CD11c
+
cells isolated from tolerized WT and PPARgDAPC mice were incubated in the
presence or absence of 10 mMPF6-AM (Adooq Bioscience) with or without an-
tigen (10 mg/ml OVA or 1 mg/ml nDerp 1) for 40 min at 37C. After washing to
remove OVA and excess PF6-AM, cells were fixed with 4% paraformaldehyde
(PFA) at 4C for 15 min. For positive control, PF6-AM-loaded cells were
exposed to 100 mMH2O2 for 15 min before fixing with PFA. To ascertain spec-
ificity of PF6-AM for H2O2, 10 mMcatalase was added to cells along with exog-
enous H2O2. Fixed cells were cytospun onto clean glass slides and processed
for imaging. Thresholds were initially set for both WT and PPARg-deficient
cells to minimize nonspecific background signal due to autofluorescence.
The images were captured using Olympus Fluoview 1000 confocal micro-
scope with a 203 objective, and quantification was performed using Nikon
NIS-Elements software based on uniformly set intensity threshold and normal-
ized per nucleus.Cell Reports 15, 1700–1714, May 24, 2016 1711
Complex I and Complex III Assay Activity
Complex I and complex III assays were performed in CD11c+ cells lysed by
three cycles of freeze/thaw as previously described (Shiva et al., 2007). Briefly,
complex I activity was measured by spectrophotometrically monitoring the
Rot-sensitive oxidation of NADH at 340 nm. Complex III activity was assessed
by spectrophotometrically monitoring the reduction of cytochrome c (550 nm)
in the presence of ubiquinol.
DMNQ Treatment
Lung CD11c+ cells were sorted from tolerized WT and PPARgDAPC mice, and
they were treated ex vivo with 200 mM DMNQ (Enzo Life Sciences) for 1 hr at
37C. Effects on intracellular H2O2 and IkB levels were assessed as described
above.
Measurement of OCR
OCR of CD11c+ cells isolated from tolerized WT and PPARgDAPC mice was
measured at the basal level. One batch of cells in each group was treated
with 200 mM Eto and thereafter with 1 mM Oligo, 1.5 mM FCCP, and 0.1 mM
Rot plus 1 mM Ant A using the XF-96 Seahorse system. Cells were plated in
triplicate. Seahorse assays were performed in unbuffered DMEM supple-
mented with 2.5 mM glucose and 1 mM glutamine.
mtDNA Estimation Assay
To determine the ratio of mtDNA to nuclear DNA in CD11c+ cells from naive
and tolerized WT and PPARgDAPC mice, 2DDCt was calculated using differ-
ence in Ct values of nucleus-encoded h19 gene and mitochondria-encoded
nd1 for each individual sample.
Assessment of Mitochondrial Morphology and Volume
Formalin-fixed CD11c+ cells from naive and tolerized (OVA and Derp1) WT
and PPARgDAPC mice were stained using anti-Tom20 (SC-11416, Santa
Cruz Biotechnology) to label mitochondria. Cells were co-stained with phal-
loidin-cy3 (to stain F-actin; R415, Life Technologies) and DAPI (to stain
nuclei; Southern Biotech). Confocal z stacks were collected using a 603
(1.43 numerical aperture [NA]) optic on a Nikon A1 equipped with GASP de-
tectors and NIS Elements software (Nikon). The confocal datasets were de-
convolved using the 3D Landweber capabilities of Nikon Elements and then
imported into Imaris software (Bitplane) for surface rendering and calculation
of mitochondrial volumes. Mitochondrial fragmentation was assessed using
the sphericity parameter (defined as the ratio of the surface area of the given
object to the surface area of a sphere with the same volume as the given
object).
Statistical Analyses
Student’s unpaired two-tailed t test was used for comparisons between two
groups. One-way ANOVA with Tukey’s post hoc test was used for compari-
sons among multiple groups, when appropriate. Differences between groups
were considered significant when p < 0.05. All statistical analyses were
performed using Prism 5 software (GraphPad).
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